Sermorelin is a short, lab-made copy of a natural hormone that tells the pituitary gland to release growth hormone. People search for sermorelin dosage because it is talked about online for muscle and body composition. This guide explains what the published research says about sermorelin dosage, how freeze-dried sermorelin is usually mixed and stored in a lab, and how it differs from ipamorelin and CJC-1295. It describes research only and is not advice for any person.
What Is Sermorelin?
Sermorelin is a chain of 29 amino acids. Amino acids are the building blocks of proteins. Your brain makes a hormone called growth hormone-releasing hormone, or GHRH, that signals the pituitary gland to release growth hormone (GH). A 1999 review in the journal BioDrugs describes sermorelin as the shortest man-made piece of GHRH that still has its full activity. It is a copy of the first 29 building blocks of the natural hormone.
Sermorelin has a real medical history. The US Anti-Doping Agency (USADA) reports that the FDA approved sermorelin products in 1990 and 1997 to treat children with low growth hormone and to test how well the pituitary gland works. The makers stopped selling them in 2008. Today it is mostly found through compounding pharmacies, according to USADA.
Sermorelin and Muscle Development
Growth hormone matters for muscle and body fat, so compounds that raise it draw interest. Sermorelin does not add growth hormone from outside. It prompts the pituitary gland to release its own.
What does the evidence say about muscle? A 2020 review in Translational Andrology and Urology says growth hormone secretagogues, which include sermorelin, are potent stimulators of GH and IGF-1 and may improve body composition, but clinical data remain limited. A 2026 review in the Journal of Sports Medicine and Physical Fitness adds that most studies used controlled medical regimens, not the amounts common in bodybuilding.
See also: Why Muscle-Building Peptides Are the Fitness Industry’s Next Frontier
Sermorelin Benefits and Uses
Sermorelin has been used or discussed for several purposes. Only the first two are documented medical uses. The rest are ideas, and the table shows how much evidence backs each one.
| Use | Status | What the research says |
|---|---|---|
| Testing the pituitary gland in children | Past approved use | A 1999 review reports that one intravenous dose works as a quick test for growth hormone deficiency. |
| Treating low growth hormone in children | Past approved use | The same review reports catch-up growth in most treated children. In a 1993 trial of 60 children, those on sermorelin-type treatment grew about 9 cm a year, compared with about 15 cm a year on growth hormone itself. |
| Muscle growth and body fat in healthy adults | Promoted online, not proven | Reviews call these compounds potent stimulators of GH and IGF-1 but say clinical evidence of real effects is limited. |
| Low testosterone in men | Early idea | A 2020 review looked at them as a possible add-on to testosterone and said data are lacking. |
| Anti-aging and adult growth hormone decline | Open question | A 2006 paper asked whether sermorelin could be a better approach for adult-onset growth hormone insufficiency. Wikipedia’s summary notes no conclusive results. |
| Athletic performance | Prohibited | The World Anti-Doping Agency bans it, according to a 2021 study. |
In plain terms, the proven uses are medical and involve children with a confirmed condition. Muscle and anti-aging uses in healthy adults are not proven.
How Sermorelin Works
Think of the pituitary gland as a faucet and GHRH as the hand that turns it on. Sermorelin acts like that hand. The 1999 review says it stimulates growth hormone release from the front part of the pituitary gland. Growth hormone then travels in the blood and tells the liver to make IGF-1, which helps tissues grow and repair.
Sermorelin does not last long. A 1994 study in the Journal of Clinical Endocrinology and Metabolism measured how fast the body clears this same 29 amino acid fragment in 10 healthy men. The disappearance half-time was about 4 minutes.
See also: CJC-1295 and Ipamorelin in Research Studies Explained
Sermorelin Dosage in Published Research
There is no approved or proven sermorelin dose for healthy adults, and this guide does not recommend one. The only doses that appear in the peer-reviewed papers reviewed here were tested in medical trials of children with diagnosed growth hormone deficiency.
What the published literature reports:
- For testing. The 1999 review says a single intravenous amount of 1 microgram for each kilogram of body weight was used as a diagnostic test.
- For treatment in children. The same review says a once-daily bedtime injection under the skin of 30 micrograms per kilogram was used in some children with idiopathic growth hormone deficiency. A 1993 trial of 60 children compared 30 and 60 micrograms per kilogram a day for 6 months and found no meaningful difference in growth.
These are weight-based figures from pediatric trials of an approved medicine. They are history, not a guide for any adult. No peer-reviewed source reviewed here gives an adult amount. Exact adult numbers on clinic, shop, and calculator sites are not from clinical trials, so this guide does not repeat them.
How freeze-dried sermorelin is usually handled in a lab
Sermorelin research material is often a freeze-dried powder. The supplier’s Certificate of Analysis and handling sheet are the main reference, because they list the exact amount in each vial. These general steps apply to most freeze-dried peptides.
- Read the supplier’s handling sheet and note the amount in the vial.
- Let the vial come to room temperature, and wipe the rubber stopper with an alcohol swab.
- Use the diluent the supplier names. Researchers typically use bacteriostatic water as the diluent.
- Add the liquid slowly along the inside wall of the vial, not straight onto the powder.
- Swirl gently until clear. Do not shake.
- Label the vial with the date and the final concentration. The Concentration Calculator helps work out the concentration, and the peptide reconstitution guide explains the math in more detail.
For storage, Mayo Clinic says the medicine form is kept in a refrigerator and must not be frozen. Research material may follow different rules, so check the supplier’s sheet first.
See also: Peptide Reconstitution Ratios & How to Calculate Them
HORMONE THERAPY
Ipamorelin
Sermorelin Side Effects and Safety
The record below comes from medical use in children and reviews of misuse. It is not a prediction for any person.
- Common. Mayo Clinic lists injection-site reactions, such as pain, redness, and swelling, as the more common effects.
- Rare. Mayo Clinic lists itching, dizziness, flushing, headache, and sleepiness.
- Antibodies. In the 1993 trial, nearly all children given the sermorelin-type treatment developed antibodies against it.
- Misuse risks. USADA lists swelling in the face and limbs, joint and nerve pain, insulin resistance, high blood pressure, and heart problems as risks tied to misuse. A 2026 review adds cardiovascular strain and says products from unregulated supply are often mislabeled or contaminated.
Sermorelin vs Ipamorelin and CJC-1295
All three are studied for raising growth hormone, but they do it in different ways. For a longer comparison, see the ipamorelin vs sermorelin guide.
| Feature | Sermorelin | Ipamorelin | CJC-1295 |
|---|---|---|---|
| What it is | 29 amino acid piece of GHRH | 5 amino acid peptide | Altered GHRH analog |
| Signal it follows | The GHRH signal | The ghrelin (hunger hormone) signal | The GHRH signal |
| Receptor | GHRH receptor | Ghrelin-type receptor | GHRH receptor |
| Main use | Testing and treating low growth hormone in children, in the past | Lab research on selective growth hormone release, and promoted online for muscle | Research on raising growth hormone, and promoted online for muscle |
| Regulatory history | Once approved, now discontinued | No approved product | No approved product |
A 1998 paper in the European Journal of Endocrinology describes ipamorelin as the first selective growth hormone secretagogue. In lab tests it released growth hormone without raising the stress hormones ACTH and cortisol, unlike older compounds in its class. A 2026 review in Frontiers in Endocrinology groups sermorelin and CJC-1295 as GHRH analogs and ipamorelin as a growth hormone secretagogue. Because they act in different ways, an amount used for one does not carry over to another.
See also: Ipamorelin Benefits, What the Research Examines
Frequently Asked Questions
What is sermorelin used for?
Its documented uses are testing and treating children with low growth hormone. People also talk about it for muscle, body fat, and anti-aging in adults, but those uses are not proven.
Is there a proven sermorelin dose for muscle growth?
No. The only published doses come from pediatric trials in children with growth hormone deficiency.
Is sermorelin FDA approved?
It was. USADA reports the FDA approved sermorelin products in 1990 and 1997, and they were discontinued in 2008.
Key Takeaways
- Sermorelin is a 29 amino acid copy of GHRH that prompts the pituitary gland to release growth hormone.
- It was once FDA approved for testing and treating children with low growth hormone, and it was discontinued in 2008.
- No approved or proven dose exists for healthy adults. Published doses are weight-based figures from pediatric trials.
- Its documented uses are medical, in children. Muscle, body fat, and anti-aging uses in healthy adults are promoted online but not proven.
- Reported side effects include injection-site reactions, and misuse risks include blood sugar and heart concerns.
- It is prohibited in sport by the World Anti-Doping Agency.
Research Use Disclaimer
This content is provided for Research Use Only (RUO). The compounds discussed are not drugs, dietary supplements, foods, or cosmetics, and are not intended for human or animal consumption, diagnostic use, or therapeutic use of any kind. They have not been evaluated by the FDA for safety or efficacy in humans. Any research use must be conducted by qualified professionals in a controlled laboratory environment, in accordance with all applicable institutional, local, and federal regulations.
Sources
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999.
- Chen RG, et al. A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency. Acta Paediatr Suppl. 1993.
- Soule S, et al. Incorporation of D-Ala2 in growth hormone-releasing hormone-(1-29)-NH2 increases the half-life and decreases metabolic clearance in normal men. J Clin Endocrinol Metab. 1994.
- Sinha DK, et al. Beyond the androgen receptor, the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020.
- Coutinho LFD, et al. A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding, a critical review. J Sports Med Phys Fitness. 2026.
- Dominikowski A, et al. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis, bridging the gap between clinical evidence and patient self-administration. Front Endocrinol. 2026.
- Memdouh S, et al. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Test Anal. 2021.
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998.
- US Anti-Doping Agency. Athletes, know sermorelin. Spirit of Sport.
- Mayo Clinic. Sermorelin (injection route). Drugs and Supplements.
- Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006.
- Wikipedia contributors. Sermorelin. Wikipedia, The Free Encyclopedia.
Explore the hormone therapy research category for related compounds, or view the Ipamorelin research material.
